Literature DB >> 32907862

Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer.

Surya Kiran Aedma1, Anusha Chidharla2, Sarah Kelting3, Anup Kasi4.   

Abstract

A 54-year-old man with stage IV B metastatic colorectal cancer with liver and peritoneal metastasis was treated with cytoreductive surgery (extended left colectomy, right partial hepatectomy, resection of right diaphragm nodule) and perioperative oxaliplatin-based chemotherapy. The patient was cancer-free for 6 months, at which point a surveillance positron emission tomography-CT scan showed metabolically active hepatosplenic lesions and mediastinal and bilateral hilar lymph nodes. An endobronchial ultrasound bronchoscopy-guided fine needle aspiration of the mediastinal and hilar lymph nodes revealed non-necrotising granulomas. The workup was negative for bacterial, fungal or mycobacterial infection, cancer or autoimmune disease. Carcinoembryonic antigen and COLVERA (a circulating tumour DNA liquid biopsy test for the detection of recurrent colon cancer) tests were negative. Subsequently the rare diagnosis of a sarcoidosis-like reaction from oxaliplatin-based chemotherapy was made. Repeat imaging after 3 months showed resolution of the hepatosplenic lesions and lymphadenopathy, alike. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer intervention; contraindications and precautions; oncology

Mesh:

Substances:

Year:  2020        PMID: 32907862      PMCID: PMC7481089          DOI: 10.1136/bcr-2019-229548

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Stable disease in advanced colorectal cancer: therapeutic implications.

Authors:  Lara Maria Pasetto; Mario Rosario D'Andrea; Antonio Jirillo; Elena Rossi; Silvio Monfardini
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

2.  Fatal diffuse alveolar damage associated with oxaliplatin administration.

Authors:  Jack Watkins; Julian H Slade; Alex Phan; Cathy Eng; Annikka Weissferdt; Michael J Overman
Journal:  Clin Colorectal Cancer       Date:  2011-04-28       Impact factor: 4.481

3.  Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report.

Authors:  Eun Joo Lee; Sang Yeub Lee; Kwang Ho In; Chul Hwan Kim; Sanghoon Park
Journal:  Med Princ Pract       Date:  2011-10-20       Impact factor: 1.927

Review 4.  New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.

Authors:  Robert P Baughman; Jan C Grutters
Journal:  Lancet Respir Med       Date:  2015-07-20       Impact factor: 30.700

5.  Association between vitamin D deficiency and tuberculosis in a Korean population.

Authors:  J Y Hong; S Y Kim; K S Chung; E Y Kim; J Y Jung; M S Park; Y S Kim; S K Kim; J Chang; Y A Kang
Journal:  Int J Tuberc Lung Dis       Date:  2014-01       Impact factor: 2.373

6.  FDA drug approval summaries: oxaliplatin.

Authors:  Amna Ibrahim; Steven Hirschfeld; Martin H Cohen; Donna J Griebel; Grant A Williams; Richard Pazdur
Journal:  Oncologist       Date:  2004

7.  Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases.

Authors:  Brad E Wilcox; Jay H Ryu; Sanjay Kalra
Journal:  Respir Med       Date:  2007-10-22       Impact factor: 3.415

8.  Fatal pneumonitis induced by oxaliplatin.

Authors:  Sara Arévalo Lobera; Naiara Sagastibeltza Mariñelarena; Ibone Elejoste Echeberría; Mireia Melé Olivé; Larraitz Egaña Otaño; Laura Basterretxea Badiola; Adelaida La Casta Muñoa; Mikel Azkue Gabilondo
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

Review 9.  Drug-Induced Sarcoidosis-Like Reactions.

Authors:  Amit Chopra; Amit Nautiyal; Alexander Kalkanis; Marc A Judson
Journal:  Chest       Date:  2018-04-24       Impact factor: 9.410

10.  Sarcoidosis associated with oxaliplatin-based chemotherapy for colorectal cancer.

Authors:  Ji Hoon Choi; Jung A Shin; Hye Kyeong Park; Su Young Kim; Hoon Jung; Sung-Soon Lee; Hye Ran Lee; Hyeon-Kyoung Koo
Journal:  Case Rep Oncol Med       Date:  2014-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.